Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis.

Takenaka S, Asano Y, Shinoda J, Nomura Y, Yonezawa S, Miwa K, Yano H, Iwama T.

Neurol Med Chir (Tokyo). 2014;54(4):280-9. Epub 2013 Dec 5.

PMID:
24305028
[PubMed - in process]
Free Article
2.

Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy.

Terakawa Y, Tsuyuguchi N, Iwai Y, Yamanaka K, Higashiyama S, Takami T, Ohata K.

J Nucl Med. 2008 May;49(5):694-9. doi: 10.2967/jnumed.107.048082. Epub 2008 Apr 15.

PMID:
18413375
[PubMed - indexed for MEDLINE]
Free Article
3.
4.

Comparison of F-18 FDG and C-11 methionine PET/CT for the evaluation of recurrent primary brain tumors.

Tripathi M, Sharma R, Varshney R, Jaimini A, Jain J, Souza MM, Bal J, Pandey S, Kumar N, Mishra AK, Mondal A.

Clin Nucl Med. 2012 Feb;37(2):158-63. doi: 10.1097/RLU.0b013e318238f51a.

PMID:
22228339
[PubMed - indexed for MEDLINE]
5.

Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.

Tsuyuguchi N, Takami T, Sunada I, Iwai Y, Yamanaka K, Tanaka K, Nishikawa M, Ohata K, Torii K, Morino M, Nishio A, Hara M.

Ann Nucl Med. 2004 Jun;18(4):291-6.

PMID:
15359921
[PubMed - indexed for MEDLINE]
6.

Comparison of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET in differentiating radiation necrosis from recurrent glioma.

Enslow MS, Zollinger LV, Morton KA, Butterfield RI, Kadrmas DJ, Christian PE, Boucher KM, Heilbrun ME, Jensen RL, Hoffman JM.

Clin Nucl Med. 2012 Sep;37(9):854-61. doi: 10.1097/RLU.0b013e318262c76a.

PMID:
22889774
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography.

Kato T, Shinoda J, Nakayama N, Miwa K, Okumura A, Yano H, Yoshimura S, Maruyama T, Muragaki Y, Iwama T.

AJNR Am J Neuroradiol. 2008 Jun;29(6):1176-82. doi: 10.3174/ajnr.A1008. Epub 2008 Apr 3.

PMID:
18388218
[PubMed - indexed for MEDLINE]
Free Article
8.

11C-methionine PET for grading and prognostication in gliomas: a comparison study with 18F-FDG PET and contrast enhancement on MRI.

Singhal T, Narayanan TK, Jacobs MP, Bal C, Mantil JC.

J Nucl Med. 2012 Nov;53(11):1709-15. doi: 10.2967/jnumed.111.102533. Epub 2012 Oct 10.

PMID:
23055534
[PubMed - indexed for MEDLINE]
Free Article
9.

Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.

Bisdas S, Ritz R, Bender B, Braun C, Pfannenberg C, Reimold M, Naegele T, Ernemann U.

Invest Radiol. 2013 May;48(5):295-301. doi: 10.1097/RLI.0b013e31827188d6.

PMID:
23296081
[PubMed - indexed for MEDLINE]
10.

Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.

Borbély K, Nyáry I, Tóth M, Ericson K, Gulyás B.

J Neurol Sci. 2006 Jul 15;246(1-2):85-94. Epub 2006 Mar 6.

PMID:
16603193
[PubMed - indexed for MEDLINE]
11.

Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.

Kaschten B, Stevenaert A, Sadzot B, Deprez M, Degueldre C, Del Fiore G, Luxen A, Reznik M.

J Nucl Med. 1998 May;39(5):778-85.

PMID:
9591574
[PubMed - indexed for MEDLINE]
Free Article
12.

Accurate differentiation of recurrent gliomas from radiation injury by kinetic analysis of α-11C-methyl-L-tryptophan PET.

Alkonyi B, Barger GR, Mittal S, Muzik O, Chugani DC, Bahl G, Robinette NL, Kupsky WJ, Chakraborty PK, Juhász C.

J Nucl Med. 2012 Jul;53(7):1058-64. doi: 10.2967/jnumed.111.097881. Epub 2012 May 31.

PMID:
22653792
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Differential diagnosis between radiation necrosis and glioma progression using sequential proton magnetic resonance spectroscopy and methionine positron emission tomography.

Nakajima T, Kumabe T, Kanamori M, Saito R, Tashiro M, Watanabe M, Tominaga T.

Neurol Med Chir (Tokyo). 2009 Sep;49(9):394-401.

PMID:
19779283
[PubMed - indexed for MEDLINE]
Free Article
14.

[Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas].

Yamaguchi S, Terasaka S, Kobayashi H, Narita T, Hirata K, Shiga S, Usui R, Tanaka S, Kubota K, Murata J, Asaoka K.

No Shinkei Geka. 2010 Jul;38(7):621-8. Japanese.

PMID:
20628188
[PubMed - indexed for MEDLINE]
15.

11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas.

Li FM, Nie Q, Wang RM, Chang SM, Zhao WR, Zhu Q, Liang YK, Yang P, Zhang J, Jia HW, Fang HH.

Nucl Med Biol. 2012 Apr;39(3):437-42. doi: 10.1016/j.nucmedbio.2011.10.003. Epub 2011 Dec 14.

PMID:
22172386
[PubMed - indexed for MEDLINE]
16.

Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.

Van Laere K, Ceyssens S, Van Calenbergh F, de Groot T, Menten J, Flamen P, Bormans G, Mortelmans L.

Eur J Nucl Med Mol Imaging. 2005 Jan;32(1):39-51. Epub 2004 Aug 10.

PMID:
15309329
[PubMed - indexed for MEDLINE]
17.

Clinical usefulness of 11C-MET PET and 201T1 SPECT for differentiation of recurrent glioma from radiation necrosis.

Sonoda Y, Kumabe T, Takahashi T, Shirane R, Yoshimoto T.

Neurol Med Chir (Tokyo). 1998 Jun;38(6):342-7; discussion 347-8.

PMID:
9689817
[PubMed - indexed for MEDLINE]
Free Article
18.

Diagnostic Value of 11C-Methionine (MET) and 18F-Fluorothymidine (FLT) Positron Emission Tomography in Recurrent High-Grade Gliomas; Differentiation from Treatment-Induced Tissue Necrosis.

Shishido H, Kawai N, Miyake K, Yamamoto Y, Nishiyama Y, Tamiya T.

Cancers (Basel). 2012 Mar 1;4(1):244-56. doi: 10.3390/cancers4010244.

PMID:
24213238
[PubMed]
Free PMC Article
19.

Detection of glioma recurrence by ¹¹C-methionine positron emission tomography and dynamic susceptibility contrast-enhanced magnetic resonance imaging: a meta-analysis.

Deng SM, Zhang B, Wu YW, Zhang W, Chen YY.

Nucl Med Commun. 2013 Aug;34(8):758-66. doi: 10.1097/MNM.0b013e328361f598.

PMID:
23670103
[PubMed - indexed for MEDLINE]
20.

L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy.

Grosu AL, Weber WA, Riedel E, Jeremic B, Nieder C, Franz M, Gumprecht H, Jaeger R, Schwaiger M, Molls M.

Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):64-74.

PMID:
16111573
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk